Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3439925 | American Journal of Obstetrics and Gynecology | 2008 | 10 Pages |
Abstract
Oral contraception usage was associated with adverse findings in several metabolic, cardiovascular, and inflammatory parameters, which is consistent with an increased future risk of cardiovascular and metabolic disease. These findings should invite more criticism of recent trends that encourage the prescription of oral contraceptives for years during reproductive life and especially in premenopausal women. In contrast, levonorgestrel-releasing intrauterine device or progestin-only pills may offer long-term health benefits over oral contraceptives and should be preferred to oral contraceptives for women in their forties and/or with metabolic risk factors for cardiovascular diseases and type 2 diabetes mellitus.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Laure MD, PhD, Hannu MD, PhD, Mark I. MD, PhD, Stephen MD, PhD, Ulla MSc, Anna-Liisa MD, PhD, Aimo MD, PhD, Maija MD, PhD, Jaana PhD, Marjo-Riitta MD, PhD, Anneli MD, PhD,